Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU5F-1 encodes the U5F variant of the U5 small nuclear RNA, a non-coding RNA component of the spliceosome complex responsible for catalyzing the removal of introns from pre-mRNA during mRNA maturation[2][3][4][5]. U5 snRNA, including its variants such as U5F, is essential for precise exon alignment and ligation; it interacts via conserved sequence motifs and secondary structures that facilitate RNA and protein binding necessary for the two catalytic steps of splicing[1][2][3]. Studies show RNU5F-1 and closely related variants are functionally assembled into snRNPs and the tri-snRNP complex (U4/U5/U6), participating in the splicing process[2]. Variants of U5 snRNA—including U5F—are present at moderate abundance in human cells and may influence alternative splicing, contributing to transcript diversity[2][3]. While pathogenic mutations in some U5 snRNA genes (e.g., RNU5B-1, RNU5A-1) are associated with rare neurodevelopmental disorders, disease-specific roles for RNU5F-1 have not been described[1]. Key notes: - RNU5F-1 is an snRNA gene variant, not a protein, receptor, or traditional drug target. - It functions as part of the major spliceosome critical for mRNA processing. - No evidence supports its role as a biomarker, drug target, or in direct disease etiology, though the family is essential for cellular function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U5F small nuclear 1 (RNU5F-1).